David L. Berstein, SVP, GC and Chief IP Officer at ARIAD PHARMACEUTICALS INC (ARIA), sold 2,400 shares at $8.22 ($20K) on 2014-04-02, disclosed to the SEC on 2014-04-03.
Scheduled sale ($20k) by SVP, GC and Chief IP Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARIA | SELL | 2016-02-03 | $141K | — | Filing → |
| ARIA | SELL | 2015-09-30 | $32K | — | Filing → |
| ARIA | SELL | 2015-07-16 | $34K | — | Filing → |